Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis

BACKGROUND: Hepatitis C virus (HCV) infection is common among people who inject drugs, yet well-described barriers mean that only a minority have accessed HCV treatment. Recent developments in HCV diagnosis and treatment facilitate innovative approaches to HCV care that improve access to, and uptake...

Descripción completa

Detalles Bibliográficos
Autores principales: McCombe, Geoff, Swan, Davina, Lambert, John S, O’Connor, Eileen, Ward, Zoe, Vickerman, Peter, Avramovic, Gordana, Crowley, Des, Tinago, Willard, Mafirakureva, Nyashadzaishe, Cullen, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449831/
https://www.ncbi.nlm.nih.gov/pubmed/35998029
http://dx.doi.org/10.2196/35300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449831/
https://www.ncbi.nlm.nih.gov/pubmed/35998029
http://dx.doi.org/10.2196/35300

Ejemplares similares